Montmorency tart cherries (Prunus cerasus L.) are rich in anthocyanins, compounds capable of augmenting fat oxidation and regulating metabolic dysfunction. The present study examined whether Montmorency tart cherry juice (MTCJ) supplementation could augment fat oxidation rates at rest and during FATMAX exercise, thus improve cardio-metabolic health. Eleven, healthy participants consumed MTCJ or placebo (PLA) twice daily, in a randomised, counterbalanced order for 20 days. Participants cycled at FATMAX for 1-h pre-, mid-(10 days) and post-supplementation whilst substrate oxidation rates were measured. Before exercise anthropometrics and resting metabolic rate were measured. Blood pressure, serum triglycerides, cholesterol, HDL, total antioxidant status (TAS) and glucose were measured immediately before and after exercise. No significant differences between conditions or interactions were observed for any functional and blood-based cardiometabolic markers or fat oxidation during exercise or rest (P > 0.05). Pre-exercise TAS (P = 0.036) and HDL (P = 0.001) were significantly reduced from mid-to post-supplementation with MTCJ only. Twenty days' MTCJ supplementation had no effect on fat oxidation; therefore, it is unnecessary for individuals in this participant cohort to consume MTCJ with exercise to improve cardio-metabolic biomarkers.
Introduction
Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide (Guo and Ling 2015) ; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardio-metabolic health are highly sought after as they possess less risk than pharmacological drugs (Vendrame et al. 2016) . Substantial evidence now exists demonstrating the relationship between high consumption of vegetables and fruits, improvements in disease symptoms and the reduced risk of disease development . However, concerns remain over the Communicated by Phillip D Chilibeck. feasibility of maintaining a high fruit and vegetable intake over a prolonged time period; therefore, daily dietary supplementation containing health-promoting phytonutrients is appealing. Subsequently, the present study supplemented small volumes of highly concentrated Montmorency tart cherry juice (MTCJ) to boost consumption of anthocyanins and thus provide sufficient amounts at physiologically relevant concentrations in a more practical and efficient method (Zheng et al. 2017 ).
Anthocyanins, a major polyphenolic sub-class of flavonoids, are predominantly responsible for the dark red, blue, black and purple pigments found in various fruits and vegetables (Wu et al. 2006) . Anthocyanins are powerful antioxidants also capable of ameliorating cardio-metabolic dysfunction (He and Giusti 2010) . A recent epidemiological study highlighted a significant correlation with anthocyanin consumption and improved long-term weight management (Bertoia et al. 2016) . Tart cherries (Prunus cerasus L.) and thus tart cherry juice possess a high phytochemical content particularly rich in specific anthocyanins, flavonols and phenolic acids (Kirakosyan et al. , 2010 . These phytochemicals are thought to contribute to effectively combating oxidative stress, inflammation and repairing muscle damage post-exercise (Bell et al. 2014b (Bell et al. , 2015 . In rodents, tart cherries have shown significant improvements at the molecular, cellular and systemic level predominantly due to modulation of peroxisome proliferator-activated receptor (PPAR) signalling pathways (Seymour et al. , 2008 . Consequently, percentage fat mass, hyperinsulinaemia, hyperlipidaemia and inflammation were all reduced (Seymour et al. , 2008 . Observations in humans have been more equivocal, with tart cherry supplementation showing no effect on blood pressure and blood-based cardio-metabolic markers in healthy participants (Lynn et al. 2014 ). More favourable findings have been reported in studies (Ataie-Jafari et al. 2008; Keane et al. 2016a, b; Martin et al. 2010 ) examining 'at risk' or diseased patients with tart cherry juice, indicating amelioration of cardio-metabolic function.
Skeletal muscle is a critical organ involved in lipid metabolism and dysfunction of cellular and molecular cascades which are implicated in the manifestation of cardiovascular disease, insulin resistance, inflammation and oxidative stress (Stump et al. 2006) . During sub-maximal exercise at FATMAX intensities [intensity eliciting maximal fat oxidation rate, conveyed as percentage of maximal oxygen uptake (%VO 2 max)], the primary source of energy is derived from oxidation of free fatty acids and intramuscular triglycerides in skeletal muscle (Romijn et al. 1993 ). Therefore, FATMAX exercise, as an intervention, was included in the present study to facilitate fat oxidation and subsequently improve cardio-metabolic function. Perez-Martin et al. (2001) conducted a study comparing substrate utilisation between healthy obese and normal-weight participants during a FATMAX determination test. An earlier shift to CHO oxidation and significantly lower maximal fat oxidation rates (MFO) were observed with obese participants compared to normal-weight, indicating metabolic inflexibility amongst the obese cohort (Perez-Martin et al. 2001) . However, in healthy participants Robinson et al. (2015) demonstrated a significant positive correlation between MFO and both 24-h fat oxidation and insulin sensitivity. Furthermore, in obese yet metabolically healthy participants, FAT-MAX training elicited a 44% increase in fat oxidation rates and 27% increase in insulin sensitivity index (Venables and Jeukendrup 2008) . A meta-analysis of FATMAX training in obese, Metabolic Syndrome and type 2 diabetic patients confirmed a shift of fat oxidation to higher exercise intensities and reductions in body weight, fat mass, waist circumference and cholesterol, thus advocating its use to improve health (Romain et al. 2012 ). Overall, these findings suggest FATMAX exercise encourages enhancements in fat oxidation rate leading to improved body composition, cholesterol and insulin sensitivity (Brun et al. 2011) .
Consequently, the purpose of specifically incorporating aerobic FATMAX exercise in the present study was twofold. First, an individualised approach to achieve maximal fat oxidation rates during moderate-intensity exercise has been suggested as the best method to reduce glycated haemoglobin (HbA 1c ), insulin-dependent glucose, fat mass and total cholesterol (Brun et al. 2011) . Second, it is an appropriate methodological test to measure the effects of an intervention on fat oxidation rates during exercise and when combined with a potential calorie restrictive mimetic (CRM), such as MTCJ, may induce additional improvements on cardiometabolic pathways and, therefore, overall health (Besnier et al. 2015) .
Rationale for the present study is based on previous work demonstrating the benefits of anthocyanin supplementation on fat oxidation rates during exercise (Cook et al. 2015 (Cook et al. , 2017 and the positive results regarding the effects of tart cherry supplementation against cardio-metabolic dysfunction in rodents (Seymour et al. , 2008 and humans (Ataie-Jafari et al. 2008; Keane et al. 2016a, b; Martin et al. 2010) . However, to date, no research has explored the cardio-metabolic responses to tart cherry supplementation and exercise in tandem; thus healthy participants were recruited to assess for any adverse effects prior to investigating responses in clinical populations. Subsequently, this study set out to examine the physiological responses of MTCJ supplementation with FATMAX exercise on fat oxidation rates, body composition and cardio-metabolic markers in healthy participants. It was hypothesised that MTCJ supplementation would augment fat oxidation rates at rest and during exercise, thus proving more efficacious at improving body composition, functional and in sera cardio-metabolic markers than previous research conducted with tart (Lynn et al. 2014; Martin et al. 2010 ) and sweet (Kelley et al. 2006 ) cherry supplementation at rest in healthy participants.
Methods

Participants
Eleven (7 males and 4 females) healthy, recreationally active (150 min moderate-intensity aerobic exercise per week), participants (mean ± SD age 30 ± 10 years, height 1.76 ± 0.09 m, body mass 76.42 ± 13.19 kg, BMI 24.43 ± 3.23 kg m −2 , V O 2 peak 35.87 ± 4.78 mL kg −1 min −1 ) volunteered for the study. All participants were non-smokers, BMI < 30, injuryfree and not diagnosed with any cardio-metabolic or renal diseases at the time of testing but had a family history of cardio-metabolic disease. Participants were instructed to cease consumption of any other supplementation 2 weeks before and for the duration of the study. All participants provided written informed consent to participate in the study and completed health screen questionnaires before the study commenced. Ethical approval was obtained from the University of Hertfordshire Health and Human Sciences Ethics Committee and the study's experimental procedures followed the principles outlined in the 1964 Declaration of Helsinki. The study was registered as a clinical trial on clinicaltrials.gov (NCT02999256).
As this was the first study to examine fat oxidation with cherries, it was difficult to confidently predict a sample size using power analyses. Previous studies that had researched the effects of fat oxidation (Cook et al. 2015; Roberts et al. 2015) or cherry supplementation (Bell et al. 2014a, b; Bowtell et al. 2011 ) had a total sample size between 10 and 16 participants.
Procedures
Research design
This study utilised a single-blind (blinded to participants), placebo-controlled, randomised, counterbalanced design, where each participant acted as their own control. Participants were required to complete two conditions over 10 weeks, differing only in supplementation, Montmorency tart cherry juice (MTCJ) and placebo (PLA). Participants were randomised to start consumption of either MTCJ or PLA first (6 received PLA first), followed by a 14-day washout period (Cook et al. 2015; Howatson et al. 2012; Keane et al. 2016a, b) and then consumption of the opposite supplement to the first condition.
Both conditions were identical in terms of design and testing procedures and comprised of 5 sessions each, with sessions lasting approximately 2.5 h. Figure 1 shows a timeline for testing sessions and the supplementation period.
Baseline measurements were obtained during the first FATMAX/VO 2 max session in the first condition. Other than blood sampling and the type of exercise itself, all other testing procedures pre-and post-exercise were identical across each session. Blood sampling was conducted pre-and post-exercise to ascertain the acute differences induced by 1 h of FATMAX exercise and pre-, mid-and post-supplementation to assess the longer-term effects of supplementation on cardio-metabolic biomarkers, within and between conditions.
Dietary and exercise guidelines
Participants were instructed to refrain from consuming water and conducting vigorous exercise 3 and 24 h before each testing session, respectively. All participants arrived at the laboratory between 7 and 10am, after an overnight fast of a minimum of 10 h, to account for circadian variation (Bell et al. 2014b) . Participants were instructed to drink fluids ad libitum and maintain their habitual polyphenol intake, particularly anthocyanins, as opposed to complete restriction throughout the study. This was to ensure that the polyphenols provided by MTCJ were supplementary to the existing habitual polyphenol intake of each participant representing normal daily activity and, therefore, upholding ecological validity (Meyer et al. 2007 ).
Total energy, macronutrient and polyphenol intake was assessed through food diaries which were completed 3 days prior to each session. In addition to replicating their 3-day diary before each testing session, a standardised menu for the final 24-h of the 3-day period, was provided to each participant based on their healthy spontaneous habitual diet to reduce day-to-day intra-individual variability in fat oxidation (Roberts et al. 2015) . Standardisation of macronutrients was set at 15% protein, 55% carbohydrate (CHO) and 30% fat of energy intake (Ben Ounis et al. 2009; Melanson et al. 2002) with 20% of the 3-day average for habitual energy intake added to account for underreporting dietary consumption with food diaries (Black et al. 1993; Mertz et al. 1991) . All participants reported 100% adherence when food diaries were assessed using dietary analysis software (Dietplan 7.0, Forestfield Software Ltd, West Sussex, UK) for percentage contributions of macronutrients to total energy intake, total polyphenols and anthocyanins.
Supplementation
The supplementation period lasted 20 days, similar to Roberts et al. (2015) , where participants ceased consumption following the 20th day and during the washout period. The experimental condition included supplementation with MTCJ (Volume: 30 mL, Energy: 102 kcal, Carbohydrates: 24.50 g of which Sugars: 17.90 g, Protein: 1.10 g and Fat: 0 g) whilst the control involved supplementation of an energy matched placebo (Volume: 30 mL, Energy: 102 kcal, Carbohydrates: 25.35 g of which Sugars: 25.32 g, Protein: 0.03 g and Fat: 0 g). The MTCJ was made with 30 mL Montmorency tart cherry concentrate (Cherry Active, Active Edge Ltd, Hanworth, UK) and 100 mL water. Placebo composition consisted of 30 mL commercially available fruit-flavoured cordial (Cherries and Berries, Morrisons, Bradford, UK), with anthocyanins used only for colouring and negligible antioxidant content, mixed with 100 mL water. In order to match placebo for energy, taste and visual appearance, a flavourless carbohydrate (Maltodextrin, My Protein Ltd, Northwich, UK), citric acid (100% Pure Citric Acid, VB and Sons, UK) and black food colouring (Morrisons, Bradford, UK) were added, respectively. Participants consumed two 130 mL servings per day, once in the morning immediately before breakfast, then again in the evening before dinner (Bell et al. 2014b (Bell et al. , 2016 . Due to fasting restrictions on testing days, participants delayed consumption of the morning serving until lunchtime. Each 30 mL serving of Montmorency tart cherry concentrate provided juice from approximately 90-110 whole Montmorency tart cherries with a total anthocyanin content of 270 mg (9 mg·mL −1 ) (Howatson et al. 2012 ).
Testing protocol
All testing sessions were conducted in a temperature-controlled laboratory kept between 21 and 24 °C and 38-45% relative humidity (dry-bulb) (AWS888N, Oregon Scientific, USA). During all testing sessions, stature (Seca 217 Stadiometer, Seca, Hamburg, Germany), body mass (Seca 799, Germany) and waist circumference (Seca 201, Germany) were measured initially, immediately followed by segmental body composition analysis (Body Composition Analyser BC-418, Tanita, Japan) via bioelectrical impedance. Body composition was measured according to the manufacturer's guidelines and specific pre-measurement conditions to reduce variability between measurements. Pilot work showed test-retest intra-individual variability (measurements taken in the morning from 5 participants according to the timeline of the study) of the body composition analyser to have coefficients of variation of 2.06% for percentage body fat and 1.91% for fat mass. Participants were not on any weight loss or weight gain regimen during this period.
After 10 min rest, resting heart rate (HR) (Polar T31c and FT1, Polar Electro Oy, Finland) and blood pressure (BP) (Omron MX3, Omron, Japan) were obtained followed by resting metabolic rate (RMR). Pre-exercise blood sampling was then performed followed by post-exercise blood sampling during the 1-h sub-maximal sessions only. Heart rate and BP were measured after post-exercise blood sampling, approximately 5-8 min after the cessation of exercise (Fig. 2a, b ).
Exercise protocols
During the first and fourth testing sessions of each condition, participants conducted FATMAX and maximal oxygen uptake ( V O 2 max ) tests.
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The FATMAX (expressed as % of V O 2 peak ) determination protocol, adapted from Achten et al. (2002) and Alkhatib et al. (2015) , required participants to cycle on an electromagnetically braked cycle ergometer (Excalibur, Lode, Groningen, The Netherlands) at 70 rev·min −1 at an initial intensity of 30 W with increments of 10 W every 3 min. The test was terminated once respiratory exchange ratio (RER) exceeded 1 for a continuous period of 30 s (Croci et al. 2014) .
The V O 2 max test was performed 15 min following the FATMAX test. Due to the low-intensity nature of the FATMAX test, 15 min provided sufficient recovery time before the V O 2 max test. The protocol for determination of V O 2 max consisted of cycling at 70-80 rev·min −1 , at an initial intensity of 100 W with wattage increasing by 20 W every minute until volitional exhaustion. The test was terminated according to BASES Sport and Exercise Physiology testing guidelines (Winter 2006) . Heart rate and differentiated (overall and legs) ratings of perceived exertion (RPE) on a 6-20 scale (Borg 1973 ) were recorded 15 s before the end of each stage for FATMAX and V O 2 max tests. RPE was also measured every 5 min during the 1-h sub-maximal exercise.
FATMAX analysis
FATMAX was determined through visual inspection of the fat oxidation curve generated from the incremental submaximal test and confirmed by identifying the highest fat oxidation rate for the final minute of each stage calculated from a 15-s rolling average of each 3 min stage. The corresponding intensity (power output, W) at the peak of this curve was deemed to be FATMAX and was implemented during the 1-h sub-maximal exercise.
The second V O 2 max and FATMAX tests were used to assess changes in fitness status (MacRae and Mefferd 2006) and any differences in FATMAX which may have occurred 1 3 due to the previous exercise sessions and supplementation. FATMAX was adjusted to the new exercise intensity for the post-supplementation 1-h sub-maximal exercise if the change in FATMAX was greater than a pre-determined threshold (> 6%).
Measures and equipment
Blood pressure and heart rate Systolic (SBP) and diastolic (DBP) blood pressure was monitored pre-and post-exercise during all testing sessions where four measurements were recorded in an upright seated position, with an average of the final three being taken as BP (Cook et al. 2015) . Resting HR was also recorded in the same anatomical position.
Resting metabolic rate RMR, resting energy expenditure, substrate oxidation rates and RER were measured pre-exercise, based on an open-circuit indirect calorimetry system (GEM Nutrition Ltd, Cheshire, UK). Participants lay supine for 30 min with data averaged for the final 20 min only, to achieve steady-state and account for any initial short-term variances in respiration (Kelly et al. 2013) . A ventilated hood was placed over the head with a flexible plastic seal around the neck and shoulders to prevent air inside and outside the hood from mixing. Participants remained silent and lay as still as possible, whilst music was played to prevent sleeping.
Respiratory gas analysis
Real-time breath-by-breath gaseous exchange data (Metalyzer 3B, Cortex Biophysik, Leipzig, Germany) 
) and RER were recorded during all exercise tests. Consequently, indirect calorimetry was used to calculate EE (kJ·min −1 ) and substrate oxidation rates (g·min −1 ) using stoichiometric equations, assuming negligible protein oxidation, specifically developed for exercise intensities between 40 and 50% V O 2 peak , as shown below (Jeukendrup and Wallis 2005) .
Exported data were analysed only from the final 50 min of all 1-h sub-maximal tests to ensure participants reached steady-state. Data were averaged for every 15 s period during the entire 50 min of exercise.
Blood sampling Venous blood, was sampled pre-and postexercise, using the butterfly method (BD Vacutainer SafetyLok Blood Collection Set 21G with Luer Adapter, Becton Dickinson and Co., Oxford, UK) from veins located in the antecubital fossa region, into one lithium heparin tube Fat oxidation rate = 1.695 ⋅VO 2 − (1.701 ⋅VCO 2 ) CHO oxidation rate = (4.344 ⋅VCO 2 ) − (3.061 ⋅VO 2 ) Energy expenditure = 0.575 ⋅VCO 2 − 4.435 ⋅VO 2 (4 mL) and one serum separator tube (4 mL) (BD Vacutainer, Becton Dickinson and Co., Oxford, UK). Tubes were centrifuged at 4000 rev·min −1 , 4 °C for 10 min (Sorvall ST 8R, Thermo Fisher Scientific, USA). Serum and plasma supernatants were aliquoted and stored at − 80 °C for later analysis. Blood samples were obtained from 10 participants, as one subject was uncomfortable with the venepuncture method.
Biochemical analysis
Plasma volume change Whole blood from lithium heparin tubes was analysed for haemoglobin (HemoCue Hb 201 + Reader, Sweden) and haematocrit to calculate plasma volume change (PVC). Haematocrit was analysed by pipetting 60 µL of whole blood into micro-haematocrit capillary tubes (Hawksley, Lancing, Sussex, UK). Tubes were then centrifuged (Haematospin 1300, Hawksley, Lancing, Sussex, UK) at 1300 rev·min −1 for 3 min. Percentage packed cell volume was determined from a slide reader (Micro Haematocrit Tube Reader, Hawksley, Lancing, Sussex, UK).
Assay results were corrected for PVC as a result of exercise-induced changes in haemoconcentration (Allgrove et al. 2011 ) by the equation shown below.
PVC was determined using the method and equations of Dill and Costill (1974) by means of comparing the pre-and post-exercise haemoglobin and haematocrit values.
Glucose Pre-and post-exercise serum samples were assessed for glucose (range 0.5-50 mmol L −1 , CV ≤ 1.5%) (Biosen C-Line, EKF Diagnostics, Cardiff, UK) in duplicates.
Total antioxidant status assay Total antioxidant capacity within serum samples was assessed in duplicates according to the manufacturer's guidelines using the total antioxidant status (Total Antioxidant Status NX2332, Randox Laboratories Ltd, Antrim, UK) colorimetric assay on a semi-automated spectrophotometer (RX Monza, Randox). Intra-assay CV was 3.49%.
Lipid assays Serum lipids were determined in duplicates using commercially available colorimetric assays on a semi-automated spectrophotometer, according to manufacturer's guidelines. Triglyceride (Triglycerides TR210, Randox) values were corrected for free glycerol by subtracting 0.11 mmol·L −1 (Stinshoff et al. 1977) , according to the manufacturer's guidelines. Intra-assay CV for triglycerCorrected assay results = %PVC × Measured post -exercise assay value.
ides, total cholesterol and HDL were 4.96, 1.99 and 4.66%, respectively. The ratio between total cholesterol and HDL was also determined. LDL was determined indirectly using the formula below (Ahmadi et al. 2008) .
Data analysis
Statistical analysis was performed using SPSS v22.0 (IBM, Chicago, USA) where data are reported as means ± SD. Data normality was checked using a Shapiro-Wilk test. Greenhouse-Geisser correction was applied upon violation of Mauchly's test of sphericity for analyses of variance (ANOVA). Statistical significance was set at P < 0.05.
A within-group 3-way, 2 × 3 × 2, condition (MTCJ vs PLA), time (pre-, mid-, post-supplementation), exercise (pre-and post-exercise), repeated-measures ANOVA with post-hoc Bonferroni's adjustment, measured differences of body mass, BMI, HR, BP, glucose, TAS, triglycerides, total cholesterol, HDL, total cholesterol:HDL, haematocrit and haemoglobin. Waist circumference, body composition and resting EE, RER, fat and CHO oxidation were analysed using a 2-way, 2 × 3 (condition × time) repeatedmeasures ANOVA design with post-hoc Bonferroni's adjustment. A paired-samples t-test was used to identify differences between individual data points within conditions and between conditions for the corresponding time point.
Parameters measured during the FATMAX and V O 2 max tests, including MFO (maximal fat oxidation) and power output at FATMAX, FATMAX (% of V O 2 peak ), RER at FAT-MAX, percentage of maximal HR (%HRmax) at FATMAX and V O 2 peak were analysed using a 2 × 2 (condition × time) repeated-measures ANOVA. A paired-samples t-test was used to identify differences between conditions for only the first and second FATMAX tests.
Variables measured during the 1-h sub-maximal exercise at FATMAX including, RER, HR, RPE (overall), RPE (legs), EE, CHO oxidation, fat oxidation and percentage contribution of fat and CHO to total EE were analysed using a 2 × 3 (condition × time) repeated-measures ANOVA with post-hoc Bonferroni's adjustment, when averaged for the final 50 min.
Partial Eta-Squared ( ) was used to report effect sizes for ANOVAs where effects were classified as small (0.01-0.08), moderate (0.09-0.25) and large (> 0.25) (Cohen 1988 ). Cohen's d effect size was used for paired-samples t-test where effects were classified as no effect (0-0.1), small (0.2-0.4), moderate (0.5-0.7) and high (≥ 0.8) (Cohen 1988) .
In order to determine whether independent variables could explain the variance observed for MFO, bivariate correlations were conducted between MFO values obtained during the final minute of the stage corresponding to FATMAX at baseline and independent variables affecting FATMAX, including age, anthropometrics, body composition, dietary intake and V O 2 peak . No significant correlations (P > 0.05) were found for any independent variables; thus regression analysis was not performed.
Results
Exercise results
1-h sub-maximal cycling tests
No significant interactions or main effects for condition and time (P > 0.05) were observed for mean EE, percentage contributions of fat and CHO to EE, V O 2 and V CO 2 , HR, overall RPE, legs RPE and serum glucose during 1-h cycling at individual FATMAX suggesting exercise intensities and physiological responses were similar between conditions over the supplementation period (Table 1) .
Mean fat oxidation rates during the final 50 min of the 1-h cycling exercise at individual FATMAX were not signific a n t ly d i f fe r e n t b et we e n (Fig. 3 ).
There were also no main effects (P > 0.05) for condition, time or the interaction for mean CHO oxidation rates.
A significant main effect for time (Pre-Supplementation: 0.88 ± 0.04, Mid-Supplementation: 0.87 ± 0.04, Post-Supplementation: 0.89 ± 0.04; F (2, 20) = 4.14; P = 0.031, 2 partial = 0.293) was detected for mean RER but not between conditions or the interaction (P > 0.05). Post-hoc analysis identified a trend towards significance between mid-supplementation and post-supplementation (P = 0.070). 10 ± 2 10 ± 1 10 ± 2 MTCJ 11 ± 2 10 ± 2 11 ± 1 RPE (Legs) (AU) PLA 10 ± 2 10 ± 2 11 ± 1 MTCJ 11 ± 2 11 ± 2 11 ± 1 significantly greater (t (10) = − 2.77; P = 0.020, d = 1.1) during the second test with MTCJ (0.90 ± 0.03) compared to PLA (0.87 ± 0.03). Paired-samples t-test between conditions did not outline any significant differences (t (10) = − 2.04; P = 0.256, d = 0.63) for the shift in wattage for FATMAX, where 3 participants increased wattage with PLA whilst 4 participants increased with MTCJ. Thus, the shift in wattage between conditions was considered negligible and not a limitation of the research.
Anthropometric and functional variables
No interactions or main effects for condition and time were detected for anthropometric measurements in Table 2 (P > 0.05). However, there was a tendency towards significantly lower percentage body fat (t (10) = 1.887; P = 0.08, d = 0.05) and fat mass (t (10) = 1.903; P = 0.08, d = 0.05) values pre-to post-supplementation with PLA compared to no difference with MTCJ for percentage body fat (t (10) = − 0.841; P = 0.42, d = 0.02) and fat mass (t (10) = − 1.386;
No interactions or main effects for condition, time and exercise (P > 0.05) were obtained for functional variables presented in Table 2 , apart from a main effect of exercise for HR (F (1,10) = 25.493; P < 0.001, 
Glucose and TAS biomarkers
No significant interactions or main effects for condition, time and exercise were detected for glucose (P > 0.05).
A main effect for time (F (2, 18) = 11.137; P = 0.001, were detected for TAS (Fig. 4) . Post-hoc analysis revealed significantly lower concentrations post-supplementation compared to mid-supplementation. There was also a tendency towards significance for the interaction between time and exercise (F (2, 18) = 3.466; P = 0.053, 2 partial = 0.28).
Pre-exercise TAS with MTCJ was significantly lower post-supplementation (1.18 ± 0.02 mmol·L −1 ; 98.92% of baseline) compared to mid-supplementation (1.33 ± 0.05 mmol·L −1 ; 111.93% of baseline) by 11.45%. In comparison, values were statistically similar with PLA (t (9) = 1.464; P = 0.177, d = 0.47) ( Table 3 ). There was a tendency towards significance (t (9) = − 1.998; P = 0.077, d = 0.71) for the difference between pre-supplementation (1.17 ± 0.03 mmol·L −1 ; 101.26% of baseline) and mid-supplementation (1.33 ± 0.05 mmol·L −1 ; 111.93% of baseline) values prior to exercise with MTCJ, but not for PLA (t (9) = − 0.556; P = 0.585, d = 0.24). After the onset of supplementation, the change in TAS during 1-h FATMAX exercise was significantly different (t (19) = 2.291; P = 0.034, d = 0.64), where an average increase of 1.75% was seen with MTCJ and a decrease of 5.17% with PLA. Table 2 Mean (± SD) for anthropometric, body composition and resting functional variables obtained pre-and/or post-exercise in both conditions at baseline and during pre-, mid-and post-supplementation trials CHO carbohydrate, DBP diastolic blood pressure, EE energy expenditure, HR heart rate, MTCJ Montmorency tart cherry juice, PLA placebo, RER respiratory exchange ratio, SBP systolic blood pressure) Denotes significant difference within condition compared to corresponding time point in the pre-supplementation trial 
Lipid biomarkers
No significant interactions or main effects for condition, time and exercise were detected for triglycerides and LDL (P > 0.05). A main effect for time only was found for HDL (F (1.3, 11 .703) = 7.098; P = 0.016, 2 partial = 0.441). Post-hoc analysis showed post-supplementation concentrations were significantly lower than mid-supplementation (P < 0.001) (Fig. 5) . As with TAS, a significant (t (9) = 3.123; P = 0.012, d = 0.68) reduction in pre-exercise HDL concentrations w a s o b s e r v e d f r o m m i d -s u p p l e m e n t a t i o n (1.84 ± 0.47 mmol.L − 1 ; 114.48% of baseline) to post-supplementation (1.56 ± 0.34 mmol·L −1 ; 98.62% of baseline) with MTCJ, whereas no difference was found for PLA (t (9) = 0.719; P = 0.490, d = 0.15) ( Table 3) .
Mean post-exercise values for total cholesterol (main effect for exercise: F (1, 9) = 8.951; P = 0.015, 
Discussion
This was the first study in any population to combine exercise and tart cherry supplementation whilst examining cardio-metabolic biomarkers. The main findings of this study were that 20 days of MTCJ supplementation did not significantly increase fat oxidation rates at rest or during FATMAX exercise, nor did it alter waist circumference, body composition or cardio-metabolic biomarkers compared to PLA.
The present study did not find significance between conditions for RER, EE, fat and CHO oxidation rates, contrasting previously reported results regarding the effect of dietary anthocyanin supplementation on substrate metabolism with exercise. Cook et al. (2015) observed a 16% increase in fat oxidation with 7 days encapsulated, anthocyanin-rich, New Zealand blackcurrant extract (NZBE) supplementation compared to placebo during cycling exercise at 65% V O 2 max . Crucially, Cook et al. (2015) instructed participants to consume one NZBE capsule, containing 105 mg anthocyanins, 2 h prior to commencing exercise thus coinciding peak bioavailability and concentrations of anthocyanins, secondary metabolites and phase II conjugates in plasma and target tissues with the time of measurement of substrate oxidation rates during exercise. This provides evidence that fat oxidation can be increased with short-term (7 days) and acute (2 h before exercise) supplementation of dietary anthocyanins and highlights the importance of timing of consumption to maximise bioavailability and concentrations in plasma and target tissues. Subsequently, the inclusion of an overnight fast may explain why Montmorency tart cherry anthocyanins and its metabolites were not able to significantly augment fat oxidation rates.
Differences in fat oxidation responses to anthocyanin supplementation may be explained by the different types of anthocyanins present compared to MTCJ. The main anthocyanins in NZBE (35-50% delphinidin-3-rutinoside and 5-20% delphinidin-3-glucoside) in NZBE are derived from the anthocyanidin, delphinidin (Cook et al. 2017) , whereas cyanidin-based anthocyanins (cyanidin-3-glucosylrutinoside and cyanidin-3-rutinoside) comprise 93% of the total anthocyanin content in Montmorency tart cherries ). It has been previously reported that delphinidinbased anthocyanins provide more effective cardio-metabolic protection than cyanidin-based anthocyanins (Overall et al. 2017) . Additionally, cyanidin is less stable in the gastrointestinal environment, although it is not dependent on gut bacteria for metabolism or absorption, whereas delphinidin is dependent on gut bacteria (Overall et al. 2017) . Healthy individuals are expected to have greater diversity and concentrations of 'good' gut bacteria, acting to increase the bioavailability of anthocyanins and their metabolites (Fernandes et al. 2014; Hidalgo et al. 2012) . Since gut bacteria do not modulate cyanidin-based anthocyanin metabolism and absorption, it is not surprising that cardio-metabolic markers or fat oxidation rates were not improved in the healthy participants from this study.
It is feasible that consumption of a fruit extract (NZBE) in capsule form would not influence substrate oxidation rates to a greater extent than supplements in juice form (MTCJ) when ingested immediately before exercise, given the likely differences in macronutrient content and metabolism such as anthocyanin degradation and absorption rates. Perhaps this explains why Cook et al. (2015) were able to observe greater fat oxidation with NZBE. Cook et al. (2015) reported NZBE anthocyanins contributed 30.70% of fat to total EE during exercise, whilst MTCJ peaked during the mid-supplementation test at 24.06% and averaged 21.48% throughout the present study. Similar results were reported with the placebo, with the most likely explanation being the high carbohydrate content of the MTCJ and placebo drinks, compared to the capsules provided in the NZBE study which were completely devoid of carbohydrate. The significant increase in resting EE was facilitated by upregulation of CHO oxidation signifying that the higher CHO content of MTCJ did induce greater glycolytic flux from days 10-20 of supplementation. This provides an explanation for the lower MFO rates and percentage contributions of fat to total EE in the present study compared to Cook et al. (2015) . The absorption of maltodextrin, present in the placebo, from the small intestine into systemic circulation, has not been proven to be different from pure glucose; therefore, the magnitude and time course of the glycaemic and insulinaemic response are expected to be similar either at rest or during exercise (Hofman et al. 2016) . However, as MTCJ contained fructose and glucose the significant elevation in CHO oxidation, at rest with MTCJ during the final 10 days of supplementation is likely due to fructose accumulation. In support of these findings, co-ingestion of glucose and fructose as opposed to either alone has been shown to significantly increase CHO oxidation rates in healthy participants (Jentjens and Jeukendrup 2005) .
The tendency towards significance for the 13.35% increase in TAS from pre-supplementation to mid-supplementation with MTCJ may explain the tendency for greater fat oxidation with MTCJ during 1-h FATMAX exercise between these time points. The increase in oxygen flux and, therefore, generation of ROS during exercise (Radak et al. 2013) , as a by-product of fatty acid oxidation at FATMAX, may have been mitigated by MTCJ antioxidants. These antioxidants may have retarded mitophagy and preserved mitochondrial function, thus enabling the continuation of fat oxidation (Montgomery and Turner 2015) . The 12.76% decrease in TAS from mid-supplementation to post-supplementation prior to exercise suggests TAS does not increase linearly with further ingestion of MTCJ after 10 days but returns to baseline. As far as the authors are aware, this is the first study to demonstrate such an effect. Consequently, this may have contributed to the different responses observed between conditions for HDL and resting EE during days 10-20 of supplementation. Endogenously derived antioxidants are the primary contributors to the antioxidant balance; thus, supplementation of exogenous antioxidants may inhibit synthesis of endogenous antioxidants in order to maintain a homeostatic balance (Poljsak et al. 2013) . Thus, it is plausible that the synthesis of endogenous antioxidants was reduced during the final 10 days of exogenous antioxidant supplementation with MTCJ resulting in a net reduction of TAS. A potential increase in oxidative stress from mid-to post-supplementation may have contributed to inefficient oxidative metabolism and thus greater resting EE (Frisard and Ravussin 2006) . These findings are supported by Timmers et al. (2011) who reported significantly lower basal EE due to improved mitochondrial function and, therefore, metabolic efficiency after 30 days' resveratrol supplementation, a potent antioxidant, in healthy, obese humans. Furthermore, the reduced synthesis/uptake of antioxidants may be a defensive mechanism against an excessively elevated antioxidant balance which may affect hormetic responses. Such is the complexity of the interactions of free radicals, pro-oxidant species, antioxidants and the cellular mechanisms involved that no one reason is liable to be responsible for this potential antioxidant effect.
In relation to lipid responses, Ataie-Jafari et al. (2008) reported tart cherry juice significantly reduced total cholesterol and LDL, whilst Martin et al. (2010) reported a significant improvement in triglycerides and VLDL. In both studies, participants were found to be hyperlipidaemic for the specific variables in which a treatment effect was observed. Likewise, studies (Kelley et al. 2006; Lynn et al. 2014) reporting non-significant differences with the cherry treatment recruited healthy participants; therefore, it is reasoned the lack of cardio-metabolic dysregulation does not provide sufficient scope for a cherry intervention to further regulate cardio-metabolic function at rest. Despite the addition of an exercise intervention, a similar reasoning can be applied to the present study, given the healthy baseline lipid concentrations presented by the participants in this study. This observation is further supported by findings presented in rodents susceptible to dyslipidaemia responding significantly better to cherry consumption than those without dyslipidaemia (Seymour et al. 2008 Wu et al. 2006) . The molecular mechanisms associated with these responses were suggested to be via increased mRNA transcription of peroxisome proliferator-activated receptor alpha (PPARα), peroxisome proliferator-activated receptor gamma (PPARγ) and hepatic activation of these isoforms by cherry anthocyanins (Seymour et al. 2008 ). Subsequently, enhancing skeletal muscle insulin sensitisation due to increased fat oxidation through sirtuin-1 mediated PPARα and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) activation (Huffman 2010) .
It is apparent accumulation of anthocyanins and their metabolites with long-term supplementation likely did not occur in the present study. This is likely due to the poor bioavailability, intestinal absorption and rapid elimination rates of anthocyanins (Manach et al. 2004 ). Alternatively, it may be that the anthocyanin and secondary metabolite concentrations in target tissues reached a ceiling level below a physiologically relevant threshold concentration (Krga et al. 2016 ) to affect serum lipids, thus explaining pre-exercise HDL responses to MTCJ consumption. A biphasic response was observed where a non-significant, yet clinically relevant, increase in HDL from pre-to mid-supplementation was followed by a significant decline from mid-to post-supplementation with MTCJ, but not PLA. Based on data from epidemiological studies with middle-age and high-risk subjects, suggesting an increase of 0.026 mmol·L −1 could reduce the risk of coronary heart disease by 2% in males (Gordon et al. 1989) , the change in HDL from pre-to mid-supplementation would result in a risk reduction of 12% with MTCJ. However, this finding should be interpreted with caution as the translation across to healthy subjects of both sexes and the lack of statistical and clinically significant improvements for other lipid profile markers with MTCJ render the increase in HDL less important. The decline from mid-to post-supplementation suggests that administering cherry interventions longer than 10 days does not maintain elevated HDL concentrations, but rather a return to baseline as supported by findings from Kelley et al. (2006) , Ataie-Jafari et al. (2008) , Martin et al. (2010) and Lynn et al. (2014) .
Given the variability in study design and supplementation strategy in the present and previous studies (Ataie-Jafari et al. 2008; Kelley et al. 2006; Lynn et al. 2014; Martin et al. 2010) it is possible to conclude that the length of supplementation, volume and concentration of juice are unlikely to be factors responsible for the equivocal results regarding lipids after cherry consumption. Rather, the initial physiological status of participants is thought to be more influential regarding the efficacy of a cherry intervention.
Finally, limitations associated with this study include the overnight fast dietary restriction put in place to reduce intraand inter-individual variability, but at the expense of upholding ecological validity. Second, previous research has shown improvements in body mass, fat mass and metabolic function required participants to exercise at FATMAX 2-4 times per week for 2-12 months (Brun et al. 2011) . Thus, Montmorency tart cherry anthocyanins were not able to compound upon any cellular and molecular adaptations promoting fat oxidation which may have occurred with FATMAX training. Third, the small sample size did not assist the ability to find significant differences with MTCJ as post-hoc power analysis suggested the study was underpowered. Additionally, due to the differences in viscosity of the placebo and MTCJ, 9 out of 11 participants correctly identified which supplement they were provided when asked at the end of the study. Consequently, this may have contributed to the lack of significance between conditions as participants could manipulate their activity during the study. This highlights a limitation of juice concentrate as a form of supplementation and perhaps alternative forms such as capsules are preferable to uphold anonymity between conditions.
Future work should attempt to elucidate the cellular and molecular mechanisms, including epigenetic changes, in humans to provide a basis upon which theories explaining the obtained responses can be either accepted or refuted. This would provide crucial information by which supplementation strategies can be altered to maximise the efficacy of MTCJ. Based on Cook et al. (2015) findings, it would be appropriate to suggest that any effect of anthocyanin supplementation on fat oxidation is short-term and provides a rationale to acutely supplement Montmorency tart cherry anthocyanins in future studies. The augmentation of fat oxidation with acute supplementation may then mitigate the development of cardiometabolic symptoms in clinical populations such as those with Metabolic Syndrome.
Conclusion
This was the first study to examine the effect of cherry supplementation on fat oxidation rates at rest and during exercise. Findings showed that MTCJ did not significantly increase fat oxidation rates at rest or during FATMAX exercise. Additionally, secondary cardio-metabolic markers were also not significantly different with MTCJ supplementation, the primary reason being that this intervention does not indicate CRM properties in healthy participants. Consequently, it is unnecessary for healthy participants to supplement MTCJ to reduce body fat percentage and improve both functional and blood-based cardio-metabolic markers. Previous studies to report a significant response to cherry supplementation in animal (Seymour et al. 2008 Wu et al. 2006 ) and human (Ataie-Jafari et al. 2008; Keane et al. 2016a, b; Martin et al. 2010 ) studies occurred when initial values were abnormal; thus further research is warranted in clinical populations.
